ADENOCARCINOMA OF THE PROSTATE

Size: px
Start display at page:

Download "ADENOCARCINOMA OF THE PROSTATE"

Transcription

1 Ref : ADENOCARCINOMA OF THE PROSTATE Div. of Urology, Dept. Surgery Medical Faculty, University of Sumatera Utara Clinical Manual of Urology, (Philip M. Hanno et al eds), McGraw-Hill Int ed, 3 rd ed, 2001 Smith s General Urology (Tanagho & McAninch eds), Lange Medical Books, 15 th ed, 2000 The most common cancer in men 2 nd most common cause of cancer related death after lung ca The choice of th/ for localized disease must be based on many factors : - grade & stage - personal preference - age - performance status Prostate tumors are generally androgen sensitive and advanced disease is most often treated by single or combined androgen ablation 1

2 Etiology Risk factor : - age > 50 - family history - ethnic origin African American >> - androgens - diet (>> animal fat) - environmental exposure - insulin-like growth factors Pathology Benign cystadenoma Prostatic intraepithelial neoplasia (PIN) - high grade (2 & 3) 30 40% chance of developing prostat Ca need repeat biopsies Malignant - conventional adenocarcinoma - transitional cell carcinoma - sarcoma - metastatic tumour - hematologic malignancies Conventional adenocarcinoma (small acinar carcinoma) Vast majority (95 97%) is adenoca from acinar epith Majority lesion in peripheral zone, 20 25% from the transitional zone Classically discovered after TURP Patterns of spread Direct extension into the seminal vesicles & extracapsularly through the periprostatic nerve routes Direct extension into the rectum is uncommon Ureteral obstruction 10 35% 2

3 Lymphatic spread is not uncommon hypogastric, obturator, external iliac, presacral, common iliac 90% distant metastate osseous Visceral meta (lung, liver, adrenal) less common Grading & Staging Gleason grade based on the degree of glandular diff and growth pattern Mostofi grade based on the degree of nuclear irregularity. The lesion are graded as well, moderately and poorly differentiated Staging systems The American Joint Committee on Cancer, modified TNM system Signs & symptoms Diagnosis A prostatic nodule or induration of the gland hallmark sign Consist of : - symptom of bladder outflow obstruction - symptom resulting from local extension - symptom from distant metastase (bone pain, low back pain, weight loss) Digital rectal examination (DRE) any palpable irregularity 50% chance TRUS very sensitive but non specific Serum marker PSA Prostate needle biopsy Bone scan CT & MRI 3

4 DRE findings that may indicate cancer : Asymmetry of the gland A nodule within one lobe of the gland Induration of part or all of the prostate Lack of mobility due to adhesion to surrounding tissue Palpable seminal vesicles Treatment for localized disease Radical or complete prostatectomy Radiation th/ : - external beam radiation th/ - interstitial brachyth/ Follow up after treatment for localized disease - serum PSA single most important parameter Treatment for advanced disease Prostate Ca is an androgen-sensitive tumor Methods of androgen ablation : - bilateral simple orchiectomy - diethylstilbesterol - DHT receptor blockade (flutamide, bicalutamide) - LHRH agonist (leuprolide) - aminoglutethimide - ketoconazole Castration - easily accomplished, relatively inexpensive, well-tolerated, almost free of complication - side effects : vasomotor instability, loss of libido, ED LHRH agonist - long term effects of bone mineralization - as effective as castration with similar side effects, administered subcutaneously 4

5 Antiandrogens - act by blocking DHT receptor - not as effective as castration or LHRH th/ - do not lower the serum testosterone level do not cause impotence or decreased libido - side effects : diarrhea & liver function abn wr07 5

Definition Prostate cancer

Definition Prostate cancer Prostate cancer 61 Definition Prostate cancer is a malignant neoplasm that arises from the prostate gland and the most common form of cancer in men. localized prostate cancer is curable by surgery or radiation

More information

Prostate Case Scenario 1

Prostate Case Scenario 1 Prostate Case Scenario 1 H&P 5/12/16: A 57-year-old Hispanic male presents with frequency of micturition, urinary urgency, and hesitancy associated with a weak stream. Over the past several weeks, he has

More information

When to worry, when to test?

When to worry, when to test? Focus on CME at the University of Calgary Prostate Cancer: When to worry, when to test? Bryan J. Donnelly, MSc, MCh, FRCSI, FRCSC Presented at a Canadian College of Family Practitioner s conference (October

More information

MODULE 8: PROSTATE CANCER: SCREENING & MANAGEMENT

MODULE 8: PROSTATE CANCER: SCREENING & MANAGEMENT MODULE 8: PROSTATE CANCER: SCREENING & MANAGEMENT KEYWORDS: Prostate cancer, PSA, Screening, Radical Prostatectomy LEARNING OBJECTIVES At the end of this clerkship, the medical student will be able to:

More information

I have no financial relationships to disclose. I WILL NOT include discussion of investigational or off-label use of a product in my presentation.

I have no financial relationships to disclose. I WILL NOT include discussion of investigational or off-label use of a product in my presentation. Prostate t Cancer MR Report Disclosure Information Vikas Kundra, M.D, Ph.D. I have no financial relationships to disclose. I WILL NOT include discussion of investigational or off-label use of a g product

More information

Prostate Overview Quiz

Prostate Overview Quiz Prostate Overview Quiz 1. The path report reads: Gleason 3 + 4 = 7. The Gleason s score is a. 3 b. 4 c. 7 d. None of the above 2. The path report reads: Moderately differentiated adenocarcinoma of the

More information

GUIDELINEs ON PROSTATE CANCER

GUIDELINEs ON PROSTATE CANCER GUIDELINEs ON PROSTATE CANCER (Text update March 2005: an update is foreseen for publication in 2010. Readers are kindly advised to consult the 2009 full text print of the PCa guidelines for the most recent

More information

What Is Prostate Cancer? Prostate cancer is the development of cancer cells in the prostate gland (a gland that produces fluid for semen).

What Is Prostate Cancer? Prostate cancer is the development of cancer cells in the prostate gland (a gland that produces fluid for semen). What Is Prostate Cancer? Prostate cancer is the development of cancer cells in the prostate gland (a gland that produces fluid for semen). It is a very common cancer in men; some cancers grow very slowly,

More information

In autopsy, 70% of men >80yr have occult prostate ca

In autopsy, 70% of men >80yr have occult prostate ca Prostate Cancer UpToDate: Introduction: Risk Factors: Biology: Symptoms: Diagnosis: Two randomized trials showed survival benefit of adding docetaxol to ADT in fit man with very high localized disease

More information

Q&A. Overview. Collecting Cancer Data: Prostate. Collecting Cancer Data: Prostate 5/5/2011. NAACCR Webinar Series 1

Q&A. Overview. Collecting Cancer Data: Prostate. Collecting Cancer Data: Prostate 5/5/2011. NAACCR Webinar Series 1 Collecting Cancer Data: Prostate NAACCR 2010-2011 Webinar Series May 5, 2011 Q&A Please submit all questions concerning webinar content through the Q&A panel Overview NAACCR 2010-2011 Webinar Series 1

More information

Collaborative Staging

Collaborative Staging Slide 1 Collaborative Staging Site-Specific Instructions Prostate 1 In this presentation, we are going to take a closer look at the collaborative staging data items for the prostate primary site. Because

More information

Prostate Cancer Case Study 1. Medical Student Case-Based Learning

Prostate Cancer Case Study 1. Medical Student Case-Based Learning Prostate Cancer Case Study 1 Medical Student Case-Based Learning The Case of Mr. Powers Prostatic Nodule The effervescent Mr. Powers is found by his primary care provider to have a prostatic nodule. You

More information

THE UROLOGY GROUP

THE UROLOGY GROUP THE UROLOGY GROUP www.urologygroupvirginia.com 1860 Town Center Drive Suite 150/160 Reston, VA 20190 703-480-0220 19415 Deerfield Avenue Suite 112 Leesburg, VA 20176 703-724-1195 224-D Cornwall Street,

More information

Chapter 18: Glossary

Chapter 18: Glossary Chapter 18: Glossary Sutter Health Cancer Service Line: Prostate Committee Advanced cancer: When the cancer has spread to other parts of the body (including lymph nodes, bones, or other organs) and is

More information

Clinical Management Guideline for Planning and Treatment. The process to be followed when a course of chemotherapy is required to treat:

Clinical Management Guideline for Planning and Treatment. The process to be followed when a course of chemotherapy is required to treat: Clinical Management Guideline for Planning and Treatment The process to be followed when a course of chemotherapy is required to treat: PROSTATE CANCER Patient information given at each stage following

More information

GUIDELINES ON PROSTATE CANCER

GUIDELINES ON PROSTATE CANCER 10 G. Aus (chairman), C. Abbou, M. Bolla, A. Heidenreich, H-P. Schmid, H. van Poppel, J. Wolff, F. Zattoni Eur Urol 2001;40:97-101 Introduction Cancer of the prostate is now recognized as one of the principal

More information

AFTER DIAGNOSIS: PROSTATE CANCER Understanding Your Treatment Options

AFTER DIAGNOSIS: PROSTATE CANCER Understanding Your Treatment Options AFTER DIAGNOSIS: PROSTATE CANCER Understanding Your Treatment Options INTRODUCTION This booklet describes how prostate cancer develops, how it affects the body and the current treatment methods. Although

More information

Case Scenario 1. 4/19/13 Bone Scan: No scintigraphic findings to suggest skeletal metastases.

Case Scenario 1. 4/19/13 Bone Scan: No scintigraphic findings to suggest skeletal metastases. Case Scenario 1 3/8/13 H&P 68 YR W/M presents w/elevated PSA. Patient is a non-smoker, current alcohol use. Physical Exam: On digital rectal exam the sphincter tone is normal and there is a 1 cm nodule

More information

Some prostatic diseases

Some prostatic diseases Some prostatic diseases Benign Prostatic Hyperplasia (Nodular Hyperplasia) Extremely common Present in a significant number of men by the age of 40 & its frequency rises progressively with age, reaching

More information

Prostate cancer staging and datasets: The Nitty-Gritty. What determines our pathological reports? 06/07/2018. Dan Berney Maastricht 2018

Prostate cancer staging and datasets: The Nitty-Gritty. What determines our pathological reports? 06/07/2018. Dan Berney Maastricht 2018 Prostate cancer staging and datasets: The Nitty-Gritty What determines our pathological reports? Dan Berney Maastricht 2018 Biopsy reporting. How not to do it. The TNM 8 th edition. Changes good and bad

More information

Challenging Cases. With Q&A Panel

Challenging Cases. With Q&A Panel Challenging Cases With Q&A Panel Case Studies Index Patient #1 Jeffrey Wieder, MD Case # 1 72 year old healthy male with mild HTN Early 2011: Preop bone scan and pelvic CT = no mets Radical prostatectomy

More information

The Return of My Cancer -Emerging Effective Therapies Jianqing Lin, MD

The Return of My Cancer -Emerging Effective Therapies Jianqing Lin, MD Februray, 2013 The Return of My Cancer -Emerging Effective Therapies Jianqing Lin, MD Why/How my cancer is back after surgery and/or radiation? Undetected micro-metastatic disease (spreading) before local

More information

Information for Patients. Prostate cancer. English

Information for Patients. Prostate cancer. English Information for Patients Prostate cancer English Table of contents What is prostate cancer?... 3 The role of hormones in prostate cancer cell growth... 3 Stages of the disease... 3 Risk factors for prostate

More information

Overview. What is Cancer? Prostate Cancer 3/2/2014. Davis A Romney, MD Ironwood Cancer and Research Centers Feb 18, 2014

Overview. What is Cancer? Prostate Cancer 3/2/2014. Davis A Romney, MD Ironwood Cancer and Research Centers Feb 18, 2014 Prostate Cancer Davis A Romney, MD Ironwood Cancer and Research Centers Feb 18, 2014 Overview Start with the basics: Definition of cancer Most common cancers in men Prostate, lung, and colon cancers Cancer

More information

Collecting Cancer Data: Prostate Q&A. Overview. NAACCR Webinar Series June 11, 2009

Collecting Cancer Data: Prostate Q&A. Overview. NAACCR Webinar Series June 11, 2009 Collecting Cancer Data: Prostate NAACCR 2008-2009 Webinar Series June 11, 2009 Q&A Please submit all questions concerning webinar content through the Q&A panel Overview 2008-2009 NAACCR Webinar Series

More information

Dr. Syah Mirsya Warli, SpU Dr. Bungaran Sihombing,SpU Div. of Urology, Surgery Dept. Medical Faculty, University of Sumatera Utara

Dr. Syah Mirsya Warli, SpU Dr. Bungaran Sihombing,SpU Div. of Urology, Surgery Dept. Medical Faculty, University of Sumatera Utara Emergency Room Urology Dr. Syah Mirsya Warli, SpU Dr. Bungaran Sihombing,SpU Div. of Urology, Surgery Dept. Medical Faculty, University of Sumatera Utara Ref : Clinical Manual of Urology, (Philip M. Hanno

More information

General information about prostate cancer

General information about prostate cancer Prostate Cancer General information about prostate cancer Key points Prostate cancer is a disease in which malignant (cancer) cells form in the tissues of the prostate. Signs of prostate cancer include

More information

BLADDER PROSTATE PENIS TESTICLES BE YO ND YO UR CA NC ER

BLADDER PROSTATE PENIS TESTICLES BE YO ND YO UR CA NC ER BLADDER PROSTATE PENIS TESTICLES THE PROSTATE IS A SMALL, WALNUT-SIZED GLAND THAT IS PART OF THE MALE REPRODUCTIVE SYSTEM. IT RESTS BELOW THE BLADDER, IN FRONT OF THE RECTUM AND SURROUNDS PART OF THE URETHRA.

More information

S1.04 Principal clinician. G1.01 Comments. G2.01 *Specimen dimensions (prostate) S2.02 *Seminal vesicles

S1.04 Principal clinician. G1.01 Comments. G2.01 *Specimen dimensions (prostate) S2.02 *Seminal vesicles Prostate Cancer Histopathology Reporting Proforma (Radical Prostatectomy) Includes the International Collaboration on Cancer reporting dataset denoted by * Family name Given name(s) Date of birth Sex Male

More information

SEER Summary Stage Still Here!

SEER Summary Stage Still Here! SEER Summary Stage Still Here! CCRA NORTHERN REGION STAGING SYMPOSIUM SEPTEMBER 20, 2017 SEER Summary Stage Timeframe: includes all information available through completion of surgery(ies) in the first

More information

INTRADUCTAL LESIONS OF THE PROSTATE. Jonathan I. Epstein

INTRADUCTAL LESIONS OF THE PROSTATE. Jonathan I. Epstein INTRADUCTAL LESIONS OF THE PROSTATE Jonathan I. Epstein Topics Prostatic intraepithelial neoplasia (PIN) Intraductal adenocarcinoma (IDC-P) Intraductal urothelial carcinoma Ductal adenocarcinoma High Prostatic

More information

LIVING WITH. Understanding Your Treatment Options 1510

LIVING WITH. Understanding Your Treatment Options 1510 Get the Support You Need Having prostate cancer can be hard to cope with. But you don t have to keep your feelings to yourself. Talk with family and friends. Try a prostate cancer support group. Sharing

More information

Survey of Clinical and Pathological Characteristics and Outcomes of Patients With Prostate Cancer

Survey of Clinical and Pathological Characteristics and Outcomes of Patients With Prostate Cancer Global Journal of Health Science; Vol. 6, No. 7; 2014 ISSN 1916-9736 E-ISSN 1916-9744 Published by Canadian Center of Science and Education Survey of Clinical and Pathological Characteristics and Outcomes

More information

BIOCHEMICAL RECURRENCE POST RADICAL PROSTATECTOMY

BIOCHEMICAL RECURRENCE POST RADICAL PROSTATECTOMY BIOCHEMICAL RECURRENCE POST RADICAL PROSTATECTOMY AZHAN BIN YUSOFF AZHAN BIN YUSOFF 2013 SCENARIO A 66 year old man underwent Robotic Radical Prostatectomy for a T1c Gleason 4+4, PSA 15 ng/ml prostate

More information

reviews LHRH Agonists in the Treatment of Advanced Carcinoma of the Prostate therapy

reviews LHRH Agonists in the Treatment of Advanced Carcinoma of the Prostate therapy reviews therapy LHRH Agonists in the Treatment of Advanced Carcinoma of the Prostate Martin I. Resnick, MD, Lester Persky Professor and Chief, Department of Urology, Case Western Reserve University School

More information

A schematic of the rectal probe in contact with the prostate is show in this diagram.

A schematic of the rectal probe in contact with the prostate is show in this diagram. Hello. My name is William Osai. I am a nurse practitioner in the GU Medical Oncology Department at The University of Texas MD Anderson Cancer Center in Houston. Today s presentation is Part 2 of the Overview

More information

Neoplasms of the Prostate and Bladder

Neoplasms of the Prostate and Bladder Neoplasms of the Prostate and Bladder 2015-2016 FCDS Educational Webcast Series Steven Peace, BS, CTR September 19, 2015 2015 Focus o Anatomy o SSS 2000 o MPH Rules o AJCC TNM 1 CDC & Florida DOH Attribution

More information

Diagnosis and Classification of Prostate Cancer

Diagnosis and Classification of Prostate Cancer Patient Information English 32 Diagnosis and Classification of Prostate Cancer The underlined terms are listed in the glossary. prostate biopsy is the only test that can confirm a prostate cancer diagnosis.

More information

What is Prostate Cancer?

What is Prostate Cancer? What is Prostate Cancer? Prostate cancer is a malignant tumor that begins in the prostate gland of men. Over 95% of prostate cancers are adenocarcinomas, cancers that develop in glandular tissue. Another

More information

Diagnosis of prostate cancer

Diagnosis of prostate cancer Diagnosis of prostate cancer Epidemiology Prostate cancer (PC) is the most common cancer in men and the 2 nd cause of cancer death in the developed world. Incidence with age, reaching 80% at age 80 (at

More information

Elevated PSA. Dr.Nesaretnam Barr Kumarakulasinghe Associate Consultant Medical Oncology National University Cancer Institute, Singapore 9 th July 2017

Elevated PSA. Dr.Nesaretnam Barr Kumarakulasinghe Associate Consultant Medical Oncology National University Cancer Institute, Singapore 9 th July 2017 Elevated PSA Dr.Nesaretnam Barr Kumarakulasinghe Associate Consultant Medical Oncology National University Cancer Institute, Singapore 9 th July 2017 Issues we will cover today.. The measurement of PSA,

More information

Outcomes of Radical Prostatectomy in Thai Men with Prostate Cancer

Outcomes of Radical Prostatectomy in Thai Men with Prostate Cancer Original Article Outcomes of Radical Prostatectomy in Thai Men with Prostate Cancer Sunai Leewansangtong, Suchai Soontrapa, Chaiyong Nualyong, Sittiporn Srinualnad, Tawatchai Taweemonkongsap and Teerapon

More information

Prostate Cancer. Diagnosis and Treatment. September 2016 Saskatchewan Prostate Assessment Pathway

Prostate Cancer. Diagnosis and Treatment. September 2016 Saskatchewan Prostate Assessment Pathway Prostate Cancer Diagnosis and Treatment September 016 Saskatchewan Prostate Assessment Pathway Table of Contents Introduction... Patient and Coach Information... Nurse Navigators... About Your Prostate...

More information

Prostate Pathology: Prostate Carcinoma, variants and Gleason Grading (Part 1)

Prostate Pathology: Prostate Carcinoma, variants and Gleason Grading (Part 1) Prostate Pathology: Prostate Carcinoma, variants and Gleason Grading (Part 1) Jae Y. Ro, MD, PhD June 7, 2012 Ten Leading Cancer Types for the Estimated New Cancer Cases and Deaths By Sex, United States,

More information

Prostate Cancer. Dr. Andres Wiernik 2017

Prostate Cancer. Dr. Andres Wiernik 2017 Prostate Cancer Dr. Andres Wiernik 2017 Objectives YES!!! 1. Epidemiology 2. Biology or Natural History of Prostate Cancer 3. Treatment NO!!! 1. Prostate Cancer Screening - controversies Which is the most

More information

Clinical Case Conference

Clinical Case Conference Clinical Case Conference Intermediate-risk prostate cancer 08/06/2014 Long Pham Clinical Case 64 yo man was found to have elevated PSA of 8.65. TRUS-biopies were negative. Surveillance PSA was 7.2 in 3

More information

AllinaHealthSystems 1

AllinaHealthSystems 1 2018 Dimensions in Oncology Genitourinary Cancer Disclosures I have no financial or commercial relationships relevant to this presentation. Matthew O Shaughnessy, MD, PhD Director of Urologic Oncology

More information

Genitourinary. Presentation Outline. Genitourinary System 12/14/2011. FCDS 2011 Educational Webcast Series December 15, 2011

Genitourinary. Presentation Outline. Genitourinary System 12/14/2011. FCDS 2011 Educational Webcast Series December 15, 2011 Genitourinary FCDS 2011 Educational Webcast Series December 15, 2011 1 Susan Smith Pierce, CTR Gema Midence, MBA, CTR Steven Peace, BS, CTR Presentation Outline Overview including Anatomy and General Information

More information

Locally advanced prostate cancer

Locally advanced prostate cancer Diagnosis Helpline 0800 074 8383 prostatecanceruk.org 1 Locally advanced prostate cancer In this fact sheet: What is locally advanced prostate cancer? What tests are used to diagnose locally advanced prostate

More information

Diagnosis and management of prostate cancer in the

Diagnosis and management of prostate cancer in the Diagnosis and management of prostate cancer in the Jeremy Teoh ( 張源津 ) Assistant Professor, Department of Surgery, The Chinese University of Hong Kong. Email: jeremyteoh@surgery.cuhk.edu.hk Estimated age-standardised

More information

Introduction. Growths in the prostate can be benign (not cancer) or malignant (cancer).

Introduction. Growths in the prostate can be benign (not cancer) or malignant (cancer). This information was taken from urologyhealth.org. Feel free to explore their website to learn more. Another trusted website with good information is the national comprehensive cancer network (nccn.org).

More information

Navigating the Stream: Prostate Cancer and Early Detection. Ifeanyi Ani, M.D. TPMG Urology Newport News

Navigating the Stream: Prostate Cancer and Early Detection. Ifeanyi Ani, M.D. TPMG Urology Newport News Navigating the Stream: Prostate Cancer and Early Detection Ifeanyi Ani, M.D. TPMG Urology Newport News Understand epidemiology of prostate cancer Discuss PSA screening and PSA controversy Review tools

More information

Edward P. Gelmann, MD

Edward P. Gelmann, MD Prostate Cancer Edward P. Gelmann, MD Prostate Cancer Etiology and Ep pidemiology Screening Pathology Staging Localized Disease Metastatic Disease normal prostate epithelium GSTP1 CpG island hypermethylation

More information

Male genital tract tumors. SiCA. Division of Urology, Department of Surgery, Faculty of Medicine Siriraj Hospital.

Male genital tract tumors. SiCA. Division of Urology, Department of Surgery, Faculty of Medicine Siriraj Hospital. Male genital tract tumors Division of Urology, Department of Surgery, Faculty of Medicine Siriraj Hospital. adenocarcinoma Prostate Cancer most common male cancer in western countries more detected in

More information

Prostate cancer presents in various ways, including

Prostate cancer presents in various ways, including Case Report 840 Presentation of Prostate Carcinoma with Cervical Lymphadenopathy: Report of Three Cases Hung-Jen Wang, MD; Po-Hui Chiang, PhD; Jyh-Ping Peng 1, MD; Tsan-Jeng Yu, MD The most common method

More information

METASTATIC PROSTATE CANCER MANAGEMENT K I R U B E L T E F E R A M. D. T R I H E A LT H C A N C E R I N S T I T U T E 0 1 / 3 1 /

METASTATIC PROSTATE CANCER MANAGEMENT K I R U B E L T E F E R A M. D. T R I H E A LT H C A N C E R I N S T I T U T E 0 1 / 3 1 / METASTATIC PROSTATE CANCER MANAGEMENT K I R U B E L T E F E R A M. D. T R I H E A LT H C A N C E R I N S T I T U T E 0 1 / 3 1 / 2 0 1 8 Prostate Cancer- Statistics Most common cancer in men after a skin

More information

Boot Camp Case Scenarios

Boot Camp Case Scenarios Boot Camp Case Scenarios Case Scenario 1 Patient is a 69-year-old white female. She presents with dyspnea on exertion, cough, and right rib pain. Patient is a smoker. 9/21/12 CT Chest FINDINGS: There is

More information

Chapter 2. Understanding My Diagnosis

Chapter 2. Understanding My Diagnosis Chapter 2. Understanding My Diagnosis With contributions from Nancy L. Brown, Ph.D.,Palo Alto Medical Foundation Research Institute; and Patrick Swift, M.D., Alta Bates Comprehensive Cancer Program o Facts

More information

PSA. HMCK, p63, Racemase. HMCK, p63, Racemase

PSA. HMCK, p63, Racemase. HMCK, p63, Racemase Case 1 67 year old male presented with gross hematuria H/o acute prostatitis & BPH Urethroscopy: small, polypoid growth with a broad base emanating from the left side of the verumontanum Serum PSA :7 ng/ml

More information

The Selenium and Vitamin E Prevention Trial

The Selenium and Vitamin E Prevention Trial The largest-ever-prostate cancer prevention trial is now underway. The study will include a total of 32,400 men and is sponsored by the National Cancer Institute and a network of researchers known as the

More information

20 Prostate Cancer Dan Ash

20 Prostate Cancer Dan Ash 20 Prostate Cancer Dan Ash 1 Introduction Prostate cancer is a disease of ageing men for which the aetiology remains unknown. The incidence rises up to 30 to 40% in men over 80. The symptoms of localised

More information

Ductal adenocarcinoma of the prostate: A clinicopathological study

Ductal adenocarcinoma of the prostate: A clinicopathological study 20 B. SATHESAN, S. A. S. GOONEWARDENA, H. W. D. ANURUDDHIKA AND M. V. C. DE SILVA Sri Lanka Journal of Urology, 2008, 9, 20-24 Original Article Ductal adenocarcinoma of the prostate: A clinicopathological

More information

Answering Your Questions. on Prostate Cancer. prostatecancer.ca

Answering Your Questions. on Prostate Cancer. prostatecancer.ca If you have questions related to this document or Prostate Cancer Canada, please contact: PROSTATE CANCER CANADA 2 Lombard Street, 3rd Floor Toronto Ontario M5C 1M1 Canada Email: info@prostatecancer.ca

More information

Men s Health Topics. Jerome Baca, MS, PA-C. Albuquerque Urology Associates January 6 th, 2018

Men s Health Topics. Jerome Baca, MS, PA-C. Albuquerque Urology Associates January 6 th, 2018 Men s Health Topics Jerome Baca, MS, PA-C Albuquerque Urology Associates January 6 th, 2018 1 ns 2 Prostate Cancer (pca) Most common type of cancer in men 45-75yo > 95% is adenocarcinoma: CA arising from

More information

Protocol for the Examination of Specimens From Patients With Carcinoma of the Prostate Gland

Protocol for the Examination of Specimens From Patients With Carcinoma of the Prostate Gland Protocol for the Examination of Specimens From Patients With Carcinoma of the Prostate Gland Version: Protocol Posting Date: June 2017 Includes ptnm requirements from the 8 th Edition, AJCC Staging Manual

More information

When PSA fails. Urology Grand Rounds Alexandra Perks. Rising PSA after Radical Prostatectomy

When PSA fails. Urology Grand Rounds Alexandra Perks. Rising PSA after Radical Prostatectomy When PSA fails Urology Grand Rounds Alexandra Perks Rising PSA after Radical Prostatectomy Issues Natural History Local vs Metastatic Treatment options 1 10 000 men / year in Canada 4000 RRP 15-year PSA

More information

Prostate MRI. Overview. Introduction 2/20/2015. Prostate cancer is most frequently diagnosed noncutaneous cancer in males (25%)

Prostate MRI. Overview. Introduction 2/20/2015. Prostate cancer is most frequently diagnosed noncutaneous cancer in males (25%) Prostate MRI John Bell, MD Introduction Prostate Cancer Screening Staging Anatomy Prostate MRI overview Functional MRI Multiparametric Approach Indications Example Cases Overview Introduction Prostate

More information

Prostate Cancer Case Study 2. Medical Student Case-Based Learning

Prostate Cancer Case Study 2. Medical Student Case-Based Learning Prostate Cancer Case Study 2 Medical Student Case-Based Learning The Case of Mr. Powers Prostate Cancer Recurrence Mr. Powers is a young appearing, healthy 73-year old male who underwent a radical prostatectomy

More information

Guidelines for the Management of Prostate Cancer West Midlands Expert Advisory Group for Urological Cancer

Guidelines for the Management of Prostate Cancer West Midlands Expert Advisory Group for Urological Cancer Guidelines for the Management of Prostate Cancer West Midlands Expert Advisory Group for Urological Cancer West Midlands Clinical Networks and Clinical Senate Coversheet for Network Expert Advisory Group

More information

Genitourinary Neoplasms Updated for 2012 Requirements and CSv02.04

Genitourinary Neoplasms Updated for 2012 Requirements and CSv02.04 Presentation Outline Genitourinary Neoplasms Updated for 2012 Requirements and CSv02.04 X:\FCDS_PUB\wwwroot\downloads\Teleconfere nces\2013 FCDS Educational Webcast Series February 28, 2013 General Information

More information

Genitourinary Neoplasms Updated for 2012 Requirements and CSv02.04

Genitourinary Neoplasms Updated for 2012 Requirements and CSv02.04 Genitourinary Neoplasms Updated for 2012 Requirements and CSv02.04 X:\FCDS_PUB\wwwroot\downloads\Teleconfere nces\2013 FCDS Educational Webcast Series February 28, 2013 1 Steven Peace, BS, CTR Susan Smith

More information

Diagnosis, pathology and prognosis including variant pathology

Diagnosis, pathology and prognosis including variant pathology PROSTATE CANCER Diagnosis, pathology and prognosis including variant pathology No Conflict of Interest Universitat Autónoma de Barcelona F.Algaba Section of Pathology PROSTATE CANCER Diagnosis, pathology

More information

Patient Information. Prostate Tissue Ablation. High Intensity Focused Ultrasound for

Patient Information. Prostate Tissue Ablation. High Intensity Focused Ultrasound for High Intensity Focused Ultrasound for Prostate Tissue Ablation Patient Information CAUTION: Federal law restricts this device to sell by or on the order of a physician CONTENT Introduction... 3 The prostate...

More information

Prostate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017

Prostate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017 Prostate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017 Dr Puay Hoon Tan Division of Pathology Singapore General Hospital Prostate cancer (acinar adenocarcinoma) Invasive carcinoma composed

More information

Case Report New Primary Malignancy Masquerading as Metastatic Prostate Adenocarcinoma

Case Report New Primary Malignancy Masquerading as Metastatic Prostate Adenocarcinoma Case Reports in Oncological Medicine Volume 2015, Article ID 358572, 5 pages http://dx.doi.org/10.1155/2015/358572 Case Report New Primary Malignancy Masquerading as Metastatic Prostate Adenocarcinoma

More information

Helen Forristal MSc (ANP) ; BSc (Hons) Professional Nursing Hormonal Treatment for Prostate Cancer ANP Candidate - Urology 2011

Helen Forristal MSc (ANP) ; BSc (Hons) Professional Nursing Hormonal Treatment for Prostate Cancer ANP Candidate - Urology 2011 Helen Forristal MSc (ANP) ; BSc (Hons) Professional Nursing Hormonal Treatment for Prostate Cancer ANP Candidate - Urology 2011 What is my Objective? If you see a patient, you may only see someone with

More information

Gross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of

Gross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of Tiền liệt tuyến Tiền liệt tuyến Gross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of solid and microcystic areas.

More information

Oncologist. The. N ews B ulletin. Cancer Medicine: Case Discussions. Progressing Prostate Carcinoma. Joan Karnell Cancer Center Pennsylvania Hospital

Oncologist. The. N ews B ulletin. Cancer Medicine: Case Discussions. Progressing Prostate Carcinoma. Joan Karnell Cancer Center Pennsylvania Hospital The Oncologist N ews B ulletin Cancer Medicine: Case Discussions Joan Karnell Cancer Center Pennsylvania Hospital Progressing Prostate Carcinoma MICHAEL J. HAUT, JOSEPH F. HARRYHILL, JEFFREY ROSENSTOCK,

More information

A Practicum Approach to CS: GU Prostate, Testis, Bladder, Kidney, Renal Pelvis. Jennifer Ruhl, RHIT, CCS, CTR Janet Stengel, RHIA, CTR

A Practicum Approach to CS: GU Prostate, Testis, Bladder, Kidney, Renal Pelvis. Jennifer Ruhl, RHIT, CCS, CTR Janet Stengel, RHIA, CTR A Practicum Approach to CS: GU Prostate, Testis, Bladder, Kidney, Renal Pelvis Jennifer Ruhl, RHIT, CCS, CTR Janet Stengel, RHIA, CTR Survey Questions and Answers 250 Responses 2 Question #1 A gentleman

More information

11/10/2015. Prostate cancer in the U.S. Multi-parametric MRI of Prostate Diagnosis and Treatment Planning. NIH estimates for 2015.

11/10/2015. Prostate cancer in the U.S. Multi-parametric MRI of Prostate Diagnosis and Treatment Planning. NIH estimates for 2015. Multi-parametric MRI of Prostate Diagnosis and Treatment Planning Temel Tirkes, M.D. Associate Professor of Radiology Director, Genitourinary Radiology Indiana University School of Medicine Department

More information

PROSTATE CANCER: A Primer of Diagnosis and Treatment. Jay C. Lee, MD, FRCSC Clinical Associate Professor University of Calgary

PROSTATE CANCER: A Primer of Diagnosis and Treatment. Jay C. Lee, MD, FRCSC Clinical Associate Professor University of Calgary PROSTATE CANCER: A Primer of Diagnosis and Treatment Jay C. Lee, MD, FRCSC Clinical Associate Professor University of Calgary Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document

More information

2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a Pseudocapsule

2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a Pseudocapsule GENITOURINARY PATHOLOGY Kathleen M. O Toole, M.D. Renal Cell Carcinoma 2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow Necrotic Mass Grossly is a Bright

More information

Saving. Kidneys. Prostate Cancer

Saving. Kidneys. Prostate Cancer Saving Kidneys 10 Prostate Cancer This booklet will tell you more about the prostate cancer. It will also help you understand this disease in a better way. You will also come to know the causes and treatment

More information

Prostate Cancer Update 2017

Prostate Cancer Update 2017 Prostate Cancer Update 2017 Arthur L. Burnett, MD, MBA, FACS Patrick C. Walsh Distinguished Professor of Urology The James Buchanan Brady Urological Institute The Johns Hopkins Medical Institutions Baltimore,

More information

NICE BULLETIN Diagnosis & treatment of prostate cancer

NICE BULLETIN Diagnosis & treatment of prostate cancer Diagnosis & treatment of prostate cancer NICE provided the content for this booklet which is independent of any company or product advertised Diagnosis and treatment of prostate cancer Introduction In

More information

A215- Urinary bladder cancer tissues

A215- Urinary bladder cancer tissues A215- Urinary bladder cancer tissues (formalin fixed) For research use only Specifications: No. of cases: 45 Tissue type: Urinary bladder cancer tissues No. of spots: 2 spots from each cancer case (90

More information

Procedures Needle Biopsy Transurethral Prostatic Resection Suprapubic or Retropubic Enucleation (Subtotal Prostatectomy) Radical Prostatectomy

Procedures Needle Biopsy Transurethral Prostatic Resection Suprapubic or Retropubic Enucleation (Subtotal Prostatectomy) Radical Prostatectomy Prostate Gland Protocol applies to invasive carcinomas of the prostate gland. Protocol web posting date: July 2006 Protocol effective date: April 2007 Based on AJCC/UICC TNM, 6 th edition Procedures Needle

More information

David Gillatt Bristol Urological Institute. David Gillatt Bristol UK

David Gillatt Bristol Urological Institute. David Gillatt Bristol UK David Gillatt Bristol Urological Institute David Gillatt Bristol UK Prostate Problems The prostate grows with age - >80% men over 60 have benign enlargement As it grows it can obstruct the flow of urine

More information

TREATMENT EFFECTS IN THE PROSTATE INCLUDING THOSE ASSOCIATED WITH EMERGING FOCAL THERAPIES

TREATMENT EFFECTS IN THE PROSTATE INCLUDING THOSE ASSOCIATED WITH EMERGING FOCAL THERAPIES TREATMENT EFFECTS IN THE PROSTATE INCLUDING THOSE ASSOCIATED WITH EMERGING FOCAL THERAPIES Andrew J. Evans MD PhD FRCPC Associate Professor and Staff Pathologist University Health Network Toronto. ON,

More information

Radiation Therapy. External Beam Radiation Therapy

Radiation Therapy. External Beam Radiation Therapy Radiation Therapy Radiation therapy is a non-invasive treatment for prostate cancer that uses x-rays or gamma-rays to eradicate prostate cancer cells. There are several forms of radiation therapy that

More information

majority of the patients. And taking an aggregate of all trials, very possibly has a modest effect on improved survival.

majority of the patients. And taking an aggregate of all trials, very possibly has a modest effect on improved survival. Hello. I am Farshid Dayyani. I am Assistant Professor in Genitourinary Medical Oncology at The University of Texas MD Anderson Cancer Center. We will be talking today about prostate cancer for survivorship

More information

Vaginal intraepithelial neoplasia

Vaginal intraepithelial neoplasia Vaginal intraepithelial neoplasia The terminology and pathology of VAIN are analogous to those of CIN (VAIN I-III). The main difference is that vaginal epithelium does not normally have crypts, so the

More information

PROSTATE CANCER. What is Prostate Cancer?

PROSTATE CANCER. What is Prostate Cancer? 1 Medical Topics - Prostate Cancer PROSTATE CANCER What is Prostate Cancer? Prostate cancer is cancer that occurs in a man's prostate a small walnut-shaped gland that produces the seminal fluid that nourishes

More information

EORTC radiation Oncology Group Intergroup collaboration with RTOG EORTC 1331-ROG; RTOG 0924

EORTC radiation Oncology Group Intergroup collaboration with RTOG EORTC 1331-ROG; RTOG 0924 EORTC radiation Oncology Group Intergroup collaboration with RTOG EORTC 1331-ROG; RTOG 0924 Title of the Study Medical Condition Androgen deprivation therapy and high dose radiotherapy with or without

More information

Prostate Cancer in comparison to Radiotherapy alone:

Prostate Cancer in comparison to Radiotherapy alone: Prostate Cancer in comparison to Radiotherapy alone: 1 RTOG 86-10 (2001) 456 patients with > a-goserelin 2 month before RTand during RT + Cyproterone acetate (1 month) vs b-pelvic irradiation (50 gy) +

More information

THE PROSTATE. SMALL GLAND BIG PROBLEM By John Crow. Chapter 4

THE PROSTATE. SMALL GLAND BIG PROBLEM By John Crow. Chapter 4 THE PROSTATE SMALL GLAND BIG PROBLEM By John Crow Chapter 4 In this chapter I want to address the big issue CANCER. What is CANCER? As you will already know, our body tissue is made up of literally Billions

More information

Prostate Gland Disorders

Prostate Gland Disorders Prostate Gland Disorders THE PROSTATE GLAND A male s prostate gland is located in the floor of the pelvis surrounding the urethra between the bladder and the penis. The prostate is positioned immediately

More information

Yes, the PET-CT report dated April 13 th 2016 was included in the structured summary reviewed by a medical oncologist at Tata Memorial Centre.

Yes, the PET-CT report dated April 13 th 2016 was included in the structured summary reviewed by a medical oncologist at Tata Memorial Centre. May 9 th 2016 Dear Mr. Ramesh Srivastava, Thank you for reaching out to Tata Memorial Centre for an expert opinion in regard to assessing your treatment options. Navya is pleased to offer this online consultation

More information

Kevin P. Hubbard, DO, HMDC, MACOI

Kevin P. Hubbard, DO, HMDC, MACOI BR Kevin P. Hubbard, DO, HMDC, MACOI Professor and Chair - Department of Specialty Medicine Kansas City University of Medicine and Biosciences-College of Osteopathic Medicine Kansas City, Missouri Financial

More information

Prostate Cancer: 2010 Guidelines Update

Prostate Cancer: 2010 Guidelines Update Prostate Cancer: 2010 Guidelines Update James L. Mohler, MD Chair, NCCN Prostate Cancer Panel Associate Director for Translational Research, Professor and Chair, Department of Urology, Roswell Park Cancer

More information